Zymeworks Inc. Financial Statements (2025 and earlier)
Company Profile
| Business Address |
SUITE 800 - 114 EAST 4TH AVENUE VANCOUVER, BC V5T 1G4 |
| State of Incorp. | BC |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 300,534 | 307,757 | 359,811 | 411,474 | 426,354 | ||||
| Cash and cash equivalent | 275,516 | 253,439 | 257,159 | 279,947 | 242,036 | ||||
| Short-term investments | 25,018 | 54,318 | 102,652 | 131,527 | 184,318 | ||||
| Receivables | 4,228 | 4,927 | 9,160 | 4,576 | 15,293 | ||||
| Other undisclosed current assets | 19,260 | 24,080 | 23,986 | 16,718 | 13,429 | ||||
| Total current assets: | 324,022 | 336,764 | 392,957 | 432,768 | 455,076 | ||||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 23,955 | 24,574 | 25,454 | 5,433 | 5,429 | ||||
| Property, plant and equipment | 25,747 | 18,560 | 13,968 | 12,305 | 12,185 | ||||
| Long-term investments and receivables | 886 | 886 | 886 | 886 | 25,921 | ||||
| Long-term investments | 886 | 886 | 886 | 886 | 25,921 | ||||
| Intangible assets, net (including goodwill) | 34,346 | 32,344 | 32,807 | 33,857 | 34,947 | ||||
| Goodwill | 12,016 | 12,016 | 12,016 | 12,016 | 12,016 | ||||
| Intangible assets, net (excluding goodwill) | 22,330 | 20,328 | 20,791 | 21,841 | 22,931 | ||||
| Prepaid expense | 17,532 | 4,280 | 2,152 | 2,149 | 2,290 | ||||
| Deferred income tax assets | 2,294 | 1,990 | 2,815 | 1,813 | 1,723 | ||||
| Other undisclosed noncurrent assets | 1,195 | 962 | 915 | 848 | 805 | ||||
| Total noncurrent assets: | 105,955 | 83,596 | 78,997 | 57,291 | 83,300 | ||||
| TOTAL ASSETS: | 429,977 | 420,360 | 471,954 | 490,059 | 538,376 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 76,334 | 56,068 | 55,582 | 43,654 | 43,655 | ||||
| Employee-related liabilities | ✕ | 5,869 | 10,320 | 8,397 | 5,536 | 9,439 | |||
| Accounts payable | 14,026 | 5,046 | 4,661 | 4,876 | 6,244 | ||||
| Other undisclosed accounts payable and accrued liabilities | 56,439 | 40,702 | 42,524 | 33,242 | 27,972 | ||||
| Debt | 27 | 22 | 22 | 22 | 17 | ||||
| Other liabilities | 27 | 22 | 22 | 22 | 17 | ||||
| Other undisclosed current liabilities | 3,583 | 19,316 | 27,379 | 26,547 | 41,977 | ||||
| Total current liabilities: | 79,971 | 75,428 | 83,005 | 70,245 | 85,666 | ||||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 30,599 | 28,742 | 30,092 | 5,333 | 5,812 | ||||
| Liabilities, other than long-term debt, including: | 36,963 | 37,261 | 37,385 | 37,336 | 2,857 | ||||
| Deferred revenue | 32,941 | 32,941 | 32,941 | 32,941 | |||||
| Deferred income tax liabilities | 1,532 | 1,749 | 1,867 | 1,515 | |||||
| Other liabilities | 2,490 | 2,571 | 2,577 | 2,880 | |||||
| Operating lease, liability | 30,599 | 28,742 | 30,092 | 5,333 | 5,812 | ||||
| Business combination, contingent consideration, liability | 1,285 | ||||||||
| Other undisclosed liabilities, other than long-term debt | 1,572 | ||||||||
| Other undisclosed noncurrent liabilities | 34,119 | ||||||||
| Total noncurrent liabilities: | 67,562 | 66,003 | 67,477 | 42,669 | 42,788 | ||||
| Total liabilities: | 147,533 | 141,431 | 150,482 | 112,914 | 128,454 | ||||
| Equity | |||||||||
| Equity, attributable to parent | 282,444 | 278,929 | 321,472 | 377,145 | 409,922 | ||||
| Common stock | 826,459 | 739,560 | 730,311 | 729,007 | 724,219 | ||||
| Additional paid in capital | 218,373 | 189,980 | 181,193 | 170,648 | 163,623 | ||||
| Accumulated other comprehensive loss | (6,659) | (6,659) | (6,659) | (6,659) | (6,659) | ||||
| Accumulated deficit | (755,729) | (643,952) | (583,373) | (515,851) | (471,261) | ||||
| Total equity: | 282,444 | 278,929 | 321,472 | 377,145 | 409,922 | ||||
| TOTAL LIABILITIES AND EQUITY: | 429,977 | 420,360 | 471,954 | 490,059 | 538,376 | ||||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,916 | (6,810) | 4,395 | 1,771 | 644 | 15,680 | ||
| Gross profit: | 1,916 | 4,395 | 1,771 | 644 | 15,680 | |||
| Operating expenses | (74,602) | (65,359) | (70,656) | (45,579) | (53,225) | |||
| Operating loss: | (72,686) | (60,964) | (68,885) | (44,935) | (37,545) | |||
| Nonoperating income (expense) | (13) | 809 | 929 | 870 | (187) | |||
| Gain, foreign currency transaction, before tax | 813 | |||||||
| Other nonoperating income (expense) | (315) | (4) | 341 | 129 | (1,224) | |||
| Loss from continuing operations before equity method investments, income taxes: | (72,699) | (60,155) | (67,956) | (44,065) | (37,732) | |||
| Other undisclosed income from continuing operations before income taxes | 340 | |||||||
| Loss from continuing operations before income taxes: | (72,699) | (59,815) | (67,956) | (44,065) | (37,732) | |||
| Income tax expense (benefit) | 74 | (764) | 434 | (525) | (161) | |||
| Loss from continuing operations: | (72,625) | (60,579) | (67,522) | (44,590) | (37,893) | |||
| Loss before gain (loss) on sale of properties: | (72,625) | ✕ | (60,579) | (67,522) | (44,590) | (37,893) | ||
| Net loss available to common stockholders, basic: | (72,625) | (60,579) | (67,522) | (44,590) | (37,893) | |||
| Other undisclosed net loss available to common stockholders, diluted | (302) | (4,538) | ||||||
| Net loss available to common stockholders, diluted: | (72,927) | (65,117) | (67,522) | (44,590) | (37,893) | |||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (72,625) | (60,579) | (67,522) | (44,590) | (37,893) | |||
| Comprehensive loss, net of tax, attributable to parent: | (72,625) | (60,579) | (67,522) | (44,590) | (37,893) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.